- Home
- OKYO vs CCG Comparison
OKYO vs CCG Comparison
Compare OKYO & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- CCG
- Stock Information
- Founded
- OKYO 2007
- CCG 2014
- Country
- OKYO United Kingdom
- CCG China
- Employees
- OKYO N/A
- CCG N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- CCG
- Sector
- OKYO Health Care
- CCG
- Exchange
- OKYO Nasdaq
- CCG Nasdaq
- Market Cap
- OKYO 77.9M
- CCG 84.5M
- IPO Year
- OKYO 2022
- CCG N/A
- Fundamental
- Price
- OKYO $2.55
- CCG $1.04
- Analyst Decision
- OKYO Strong Buy
- CCG Buy
- Analyst Count
- OKYO 1
- CCG 1
- Target Price
- OKYO $7.00
- CCG $350.00
- AVG Volume (30 Days)
- OKYO 197.8K
- CCG 230.1K
- Earning Date
- OKYO 07-18-2025
- CCG 11-25-2025
- Dividend Yield
- OKYO N/A
- CCG N/A
- EPS Growth
- OKYO N/A
- CCG N/A
- EPS
- OKYO N/A
- CCG N/A
- Revenue
- OKYO N/A
- CCG $444,290,042.00
- Revenue This Year
- OKYO N/A
- CCG N/A
- Revenue Next Year
- OKYO N/A
- CCG $15.80
- P/E Ratio
- OKYO N/A
- CCG N/A
- Revenue Growth
- OKYO N/A
- CCG N/A
- 52 Week Low
- OKYO $0.90
- CCG $0.71
- 52 Week High
- OKYO $3.35
- CCG $1.54
- Technical
- Relative Strength Index (RSI)
- OKYO 64.07
- CCG 45.49
- Support Level
- OKYO $2.11
- CCG $0.95
- Resistance Level
- OKYO $2.70
- CCG $1.04
- Average True Range (ATR)
- OKYO 0.17
- CCG 0.08
- MACD
- OKYO 0.07
- CCG -0.01
- Stochastic Oscillator
- OKYO 89.95
- CCG 38.30
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.